Initial Five Years Experience of the Ottawa Hospital Cardio-Oncology Clinic: Patient Characteristics &amp; Clinical Outcomes

Johnson, C.B.; Turek, Michel; Law, Amy; Stadnick, Ellamae; Hopkins, Sharon G.; Graham, N.; Dattilo, Franco; Dent, Sarah A.

doi:10.1016/j.cjca.2013.07.324

Cited by 1 publication

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Hence, there is a need to increase communication and ‘open the doors’ separating cardiologists and oncologists. One initiative is the creation of cardio‐oncology clinics . Cardio‐oncology clinics have been established in USA, Italy and Canada, work within cancer centres and employ cardiovascular specialists with experience in cancer care as well as nurses, nurse practitioners and professional staff.…”

Section: Resultsmentioning

confidence: 99%

“…One initiative is the creation of cardio-oncology clinics. 52 Cardio-oncology clinics have been established in USA, Italy and Canada, work within cancer centres and employ cardiovascular specialists with experience in cancer care as well as nurses, nurse practitioners and professional staff. In addition to monitoring and treating patients, these clinics have also been leaders in cardiooncology research, have developed curriculum content for fellows-in-training and raised awareness of this growing field.…”

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

Chemotherapy‐related cardiomyopathy: a neglected aspect of cancer survivorship

Nolan¹,

Lowenthal²,

Venn³

et al. 2014

Internal Medicine Journal

View full text Add to dashboard Cite

Improvements in survival from cancer have led to a large population who are at risk of late complications of chemotherapy. One of the most serious cardiovascular complications is chemotherapy-related cardiomyopathy (CRC), which may become clinically overt years or even decades after treatment and has over threefold higher mortality rate compared with idiopathic dilated cardiomyopathy. The early stages of this condition appear to respond well to cardioprotective medications (i.e. angiotensin-converting enzyme inhibitors, β-blockers). Periodic cardiac monitoring is necessary in this population to identify patients who would benefit from treatment. Cardio-oncology clinics have been established in recognition of this hazard in survivorship. This review summarises the epidemiology and pathophysiology of CRC, the evidence base for different non-invasive imaging modalities for screening and diagnosis and the rationale for treatment.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%